Patients with any adverse cytogenetic lesion have a shorter survival than those without, whereas patients with hyperdiploidy have a longer survival. Kaplan-Meier survival curves and log-rank P values are shown. (A-B) Survival analysis for patients with no adverse lesions (n = 438) vs at least 1 adverse lesion (n = 409). (A) Median PFS values: no adverse lesion, 23.3 months; adverse lesion, 15 months. (B) Median OS values: no adverse lesion, 60.6 months; adverse lesion, 33.7 months. (C-D) Survival analysis for patients with hyperdiploidy (n = 499) or without (n = 348). (C) Median PFS values: hyperdiploid, 18.8 months; nonhyperdiploidy, 16.3 months. (D) Median OS values: hyperdiploid, 49.7 months; nonhyperdiploidy, 42.8 months.